{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:32:23Z","timestamp":1781649143502,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,14]]},"DOI":"10.7759\/cureus.107014","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:50:23Z","timestamp":1776163823000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Native Joint Septic Arthritis Due to Histoplasma Capsulatum in a Patient on Adalimumab"],"prefix":"10.7759","author":[{"given":"Seth","family":"Conley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anmol","family":"Baidwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moumita","family":"Sarker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00027-06","article-title":"Histoplasmosis: a clinical and laboratory update","volume":"20","author":"Kauffman CA","year":"2007","unstructured":"Kauffman CA. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev. 2007, 20:115-32. 10.1128\/CMR.00027-06","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2019.1663596","article-title":"Sensing the heat and the host: virulence determinants of Histoplasma capsulatum","volume":"10","author":"Beyhan S","year":"2019","unstructured":"Beyhan S, Sil A. Sensing the heat and the host: virulence determinants of Histoplasma capsulatum. Virulence. 2019, 10:793-800. 10.1080\/21505594.2019.1663596","journal-title":"Virulence"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/82_2018_114","article-title":"Histoplasma capsulatum: mechanisms for pathogenesis","volume":"422","author":"Mittal J","year":"2019","unstructured":"Mittal J, Ponce MG, Gendlina I, Nosanchuk JD. Histoplasma capsulatum: mechanisms for pathogenesis. Curr Top Microbiol Immunol. 2019, 422:157-91. 10.1007\/82_2018_114","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2018.06.016","article-title":"Reactivation of dormant\/latent fungal infection","volume":"77","author":"Brunet K","year":"2018","unstructured":"Brunet K, Alanio A, Lortholary O, Rammaert B . Reactivation of dormant\/latent fungal infection. J Infect. 2018, 77:463-8.","journal-title":"J Infect"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2022.2137987","article-title":"Pathogenicity & virulence of Histoplasma capsulatum - a multifaceted organism adapted to intracellular environments","volume":"13","author":"Valdez AF","year":"2022","unstructured":"Valdez AF, Miranda DZ, Guimar\u00e3es AJ, Nimrichter L, Nosanchuk JD. Pathogenicity & virulence of Histoplasma capsulatum - a multifaceted organism adapted to intracellular environments. Virulence. 2022, 13:1900-19. 10.1080\/21505594.2022.2137987","journal-title":"Virulence"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1117\/1.JBO.25.1.015003","article-title":"Quantification of joint blood flow by dynamic contrast-enhanced near-infrared spectroscopy: application to monitoring disease activity in a rat model of rheumatoid arthritis","volume":"25","author":"Ioussoufovitch S","year":"2020","unstructured":"Ioussoufovitch S, Morrison L, Desjardins L, et al.. Quantification of joint blood flow by dynamic contrast-enhanced near-infrared spectroscopy: application to monitoring disease activity in a rat model of rheumatoid arthritis. J Biomed Opt. 2020, 25:1-10. 10.1117\/1.JBO.25.1.015003","journal-title":"J Biomed Opt"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-018-4383-0","article-title":"A case of disseminated histoplasmosis in a patient with rheumatoid arthritis on abatacept","volume":"33","author":"Jain N","year":"2018","unstructured":"Jain N, Doyon JB, Lazarus JE, et al.. A case of disseminated histoplasmosis in a patient with rheumatoid arthritis on abatacept. J Gen Intern Med. 2018, 33:769-72. 10.1007\/s11606-018-4383-0","journal-title":"J Gen Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04912-5","article-title":"Synovitis due to Histoplasma capsulatum: a case series and literature review","volume":"43","author":"Li Y","year":"2023","unstructured":"Li Y, Berianu F, Brumble L, Calamia KT. Synovitis due to Histoplasma capsulatum: a case series and literature review. Rheumatol Int. 2023, 43:763-9. 10.1007\/s00296-021-04912-5","journal-title":"Rheumatol Int"},{"key":"ref9","article-title":"Fungal infection risks associated with the use of cytokine antagonists and immune checkpoint inhibitors","volume":"245","author":"Li X","year":"2020","unstructured":"Li X, Lau SK, Woo PC. Fungal infection risks associated with the use of cytokine antagonists and immune checkpoint inhibitors. Exp Biol Med (Maywood). 2020, 245:1104-14.","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/myc.70040","article-title":"Fungal infections associated with TNF-inhibitors: a 20-year of a systematic review fungal infections and TNF-inhibitors","volume":"68","author":"Barbosa LS","year":"2025","unstructured":"Barbosa LS, Ely MM, Salom\u00e9 TM, de Almeida de Souza GH, Santos DA, Bastos RW, Rossato L. Fungal infections associated with TNF-inhibitors: a 20-year of a systematic review fungal infections and TNF-inhibitors. Mycoses. 2025, 68:e70040. 10.1111\/myc.70040","journal-title":"Mycoses"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.890331","article-title":"A guide to prepare patients with inflammatory bowel diseases for anti-TNF-\u03b1 therapy","volume":"20","author":"Chebli JM","year":"2014","unstructured":"Chebli JM, Gaburri PD, Chebli LA, da Rocha Ribeiro TC, Pinto AL, Ambrogini J\u00fanior O, Dami\u00e3o AO. A guide to prepare patients with inflammatory bowel diseases for anti-TNF-\u03b1 therapy. Med Sci Monit. 2014, 20:487-98. 10.12659\/MSM.890331","journal-title":"Med Sci Monit"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/DHPS.S28801","article-title":"Clinical use of anti-TNF therapy and increased risk of infections","volume":"5","author":"Ali T","year":"2013","unstructured":"Ali T, Kaitha S, Mahmood S, Ftesi A, Stone J, Bronze MS. Clinical use of anti-TNF therapy and increased risk of infections. Drug Healthc Patient Saf. 2013, 5:79-99. 10.2147\/DHPS.S28801","journal-title":"Drug Healthc Patient Saf"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1086\/648724","article-title":"Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy","volume":"50","author":"Hage CA","year":"2010","unstructured":"Hage CA, Bowyer S, Tarvin SE, Helper D, Kleiman MB, Wheat LJ. Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy. Clin Infect Dis. 2010, 50:85-92. 10.1086\/648724","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s40475-015-0044-0","article-title":"Histoplasmosis infections worldwide: thinking outside of the Ohio river valley","volume":"2","author":"Bahr NC","year":"2015","unstructured":"Bahr NC, Antinori S, Wheat LJ, Sarosi GA. Histoplasmosis infections worldwide: thinking outside of the Ohio river valley. Curr Trop Med Rep. 2015, 2:70-80. 10.1007\/s40475-015-0044-0","journal-title":"Curr Trop Med Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac313","article-title":"Management of histoplasmosis by infectious disease physicians","volume":"9","author":"Mazi PB","year":"2022","unstructured":"Mazi PB, Arnold SR, Baddley JW, et al.. Management of histoplasmosis by infectious disease physicians. Open Forum Infect Dis. 2022, 9:ofac313. 10.1093\/ofid\/ofac313","journal-title":"Open Forum Infect Dis"},{"key":"ref16","unstructured":"Areas with histoplasmosis. (2025). Accessed. March 10, 2026: https:\/\/www.cdc.gov\/histoplasmosis\/data-research\/maps\/index.html#."},{"key":"ref17","unstructured":"Clinical practice guideline update by the Infectious Diseases Society of America on histoplasmosis. treatment of asymptomatic histoplasma pulmonary nodules (histoplasmomas) in adults, children, and pregnant people. (2025). Accessed: March 10, 2026: https:\/\/www.idsociety.org\/practice-guideline\/histoplasmosis-2025\/."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1086\/587989","article-title":"Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: case finding through the Emerging Infections Network","volume":"46","author":"Winthrop KL","year":"2008","unstructured":"Winthrop KL, Yamashita S, Beekmann SE, Polgreen PM. Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: case finding through the Emerging Infections Network. Clin Infect Dis. 2008, 46:1738-40. 10.1086\/587989","journal-title":"Clin Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-01145-8","article-title":"Long-term safety of adalimumab in 29,967 adult patients from global clinical trials across multiple indications: an updated analysis","volume":"37","author":"Burmester GR","year":"2020","unstructured":"Burmester GR, Gordon KB, Rosenbaum JT, et al.. Long-term safety of adalimumab in 29,967 adult patients from global clinical trials across multiple indications: an updated analysis. Adv Ther. 2020, 37:364-80. 10.1007\/s12325-019-01145-8","journal-title":"Adv Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036450","article-title":"Incidence of histoplasmosis in patients receiving TNF-alpha inhibitors: a systematic review and meta-analysis","volume":"102","author":"Cipolat MM","year":"2023","unstructured":"Cipolat MM, Rodrigues DR, Brenol CV, Pasqualotto AC, Falci DR. Incidence of histoplasmosis in patients receiving TNF-alpha inhibitors: a systematic review and meta-analysis. Medicine. 2023, 102:e36450. 10.1097\/MD.0000000000036450","journal-title":"Medicine"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2025.2491013","article-title":"Global prevalence of biologic drugs use in inflammatory bowel diseases: a systematic review and meta-analysis","volume":"60","author":"Tianeze de Castro C","year":"2025","unstructured":"Tianeze de Castro C, da Silva Oliveira D, Freire de Melo F, Lima Barreto M, de Souza Teles Santos CA, Barbosa Dos Santos D. Global prevalence of biologic drugs use in inflammatory bowel diseases: a systematic review and meta-analysis. Scand J Gastroenterol. 2025, 60:439-53. 10.1080\/00365521.2025.2491013","journal-title":"Scand J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/389320-a-case-of-native-joint-septic-arthritis-due-to-histoplasma-capsulatum-in-a-patient-on-adalimumab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:50:25Z","timestamp":1776163825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/389320-a-case-of-native-joint-septic-arthritis-due-to-histoplasma-capsulatum-in-a-patient-on-adalimumab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.107014","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,14]]}}}